Use of cgrp antagonist compounds for treatment of psoriasis
CA 2495498 C · Owner: Birkir Sveinsson · Inventors: Sveinsson, Birkir
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides methods and compositions for treating preventing and/ , or remedying psoriasis based on compounds that have a calcitonin-related gene peptide (CGRP) antagonistic effect. Methods are also disclosed for identifying compounds with CGRP antagonist activity which thereby are suitable candidate compounds for treating psoriasis.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 12, 2003 and granted April 15, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 12, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 12, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.